- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/587 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m ≥ 0, Z being a singly or a doubly bound hetero atom
Patent holdings for IPC class C07D 277/587
Total number of patents in this class: 20
10-year publication summary
|
2
|
0
|
1
|
1
|
3
|
0
|
3
|
3
|
0
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Board of Trustees of the University of Illinois | 2719 |
3 |
| Syngenta Crop Protection AG | 6128 |
2 |
| Amgen Inc. | 4108 |
1 |
| The General Hospital Corporation | 4770 |
1 |
| President and Fellows of Harvard College | 6002 |
1 |
| Korea Institute of Science and Technology | 2145 |
1 |
| Antabio SAS | 22 |
1 |
| Dr. Reddy's Laboratories, Inc. | 178 |
1 |
| Dr. Reddy's Laboratories Limited | 555 |
1 |
| The Hong Kong Polytechnic University | 481 |
1 |
| Ishihara Sangyo Kaisha, Ltd. | 662 |
1 |
| Kancera AB | 33 |
1 |
| Marquette University | 157 |
1 |
| The University of Electro-Communications | 216 |
1 |
| Immunic AG | 54 |
1 |
| Shenzhen Cell Inspire Pharmaceutical Development Co., Ltd. | 8 |
1 |
| Lhotse bio, Inc. | 11 |
1 |
| Other owners | 0 |